Skip to main content
. 2023 Jan 19;13:1107071. doi: 10.3389/fendo.2022.1107071

Figure 1.

Figure 1

Flow chart of the study. A total of 88 NAFLD patients who were assessed to be eligible were made up of the intent-to-treat population. These patients were randomly divided into the control group and the SLF group, and 1 patient was lost to follow up and 3 patients withdrew due to COVID-19 in the control group, whereas 2 patients in the SLF group. The remaining 82 patients made up the per-protocol population.